Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | MOR | APGE | MLTX | ||
Company | Morphosys Ag ADR | Apogee Therapeutics Inc | Moonlake Immunotherapeutics | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 18.06 | 45.32 | 41.68 | ||
High | 18.15 | 46.72 | 42.66 | ||
Low | 18.02 | 43.61 | 41.20 | ||
Last | 18.14 | 46.24 | 42.04 | ||
Change | +0.09 | -0.30 | -0.39 | ||
% Change | +0.50% | -0.64% | -0.92% | ||
Volume | 69,468 | 128,587 | 99,899 | ||
20-Day Average Volume | 338,840 | 473,518 | 402,840 | ||
Previous Close | 18.05 | 46.54 | 42.43 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 18.06 | 54.27 | 44.89 | ||
20-Day Raw Stochastic | 78.79% | 9.03% | 10.38% | ||
20-Day Relative Strength | 65.29% | 41.37% | 37.80% | ||
Weighted Alpha | +80.85 | +35.03 | +2.68 | ||
Today's Opinion | 100% Buy | N/A | 88% Sell | ||
Previous Opinion | 88% Buy | N/A | 96% Sell | ||
Last Month's Opinion | 100% Buy | N/A | 24% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +0.44% since 04/18/24 | -5.01% since 04/18/24 | -0.71% since 04/18/24 | ||
Low | 17.90 on 04/22/24 | 43.60 on 04/25/24 | 40.68 on 04/19/24 | ||
High | 18.15 on 04/25/24 | 51.00 on 04/23/24 | 43.60 on 04/24/24 | ||
1-Month | |||||
%Chg | -0.11% since 03/25/24 | -29.34% since 03/25/24 | -18.92% since 03/25/24 | ||
Low | 17.87 on 04/03/24 | 43.60 on 04/25/24 | 40.68 on 04/19/24 | ||
High | 18.20 on 04/09/24 | 69.40 on 03/28/24 | 53.20 on 03/26/24 | ||
3-Month | |||||
%Chg | +83.69% since 01/25/24 | +27.27% since 01/25/24 | -26.03% since 01/25/24 | ||
Low | 10.02 on 01/26/24 | 32.78 on 02/02/24 | 40.68 on 04/19/24 | ||
High | 18.31 on 03/12/24 | 72.29 on 03/13/24 | 64.98 on 02/12/24 | ||
6-Month | |||||
%Chg | +153.57% since 10/25/23 | +199.61% since 10/25/23 | -18.15% since 10/25/23 | ||
Low | 4.18 on 11/22/23 | 14.19 on 11/10/23 | 35.11 on 11/06/23 | ||
High | 18.31 on 03/12/24 | 72.29 on 03/13/24 | 64.98 on 02/12/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 2,718,709 | 2,720,077 | 2,710,726 | ||
Shares Outstanding, K | 150,621 | 58,446 | 63,887 | ||
Annual Sales | 257,890,000 | 0 | 0 | ||
Annual Net Income | -205,350,000 | -83,990,000 | -36,010,000 | ||
Last Quarter Sales | 63,610,000 | 0 | 0 | ||
Last Quarter Net Income | 53,170,000 | -31,740,000 | -5,330,000 | ||
60-Month Beta | 1.17 | N/A | 1.20 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.33 on 03/13/24 | -0.32 on 03/05/24 | -0.12 on 02/29/24 | ||
Latest Earnings Date | 05/01/24 | 06/04/24 | 05/10/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |